Email this article 
INFLUENCE OF DELIVERY ON PATIENTS’ ADHERENCE TO THERAPY OF BRONCHOOBSTRACTIVE DISEASES
- Authors: Shartanova NV1
-
Affiliations:
- Institute of Immunology
- Issue: Vol 11, No 5 (2014)
- Pages: 40-45
- Section: Articles
- Submitted: 10.03.2020
- Published: 15.12.2014
- URL: https://rusalljournal.ru/raj/article/view/515
- DOI: https://doi.org/10.36691/RJA515
- ID: 515
Cite item
Open Access
Access granted
Abstract
Bronchial asthma (BA) - a global public health problem worldwide. All treatments aimed at improving the control of symptoms of the disease, prevention of exacerbations and improving the quality of life for patients. The use of inhalation therapy is the basis for the treatment of all bronchoobstructive diseases. The effectiveness of treatment depends not only on the quality of the inhaled drug, but also by means of delivery of the drug into the bronchi. Easyhaler - a new dry powder inhaler, inhalation activated enables precise dosing of the drug. According to various studies, the method of delivery of drugs has proven high efficiency, ease to use and adherence of patients to the unit.
Keywords
Full Text
About the authors
N V Shartanova
Institute of Immunology
Email: nshartanova@yandex.ru
Moscow, Russia
References
- Глобальная стратегия лечения и профилактики бронхиальной астмы. Пересмотр 2006 г. Под ред. А.Г. Чучалина. М., «Атмосфера». 2007, 104 с.
- Клиническая аллергология. Руководство для практических врачей. Под ред. Р.М. Хаитова. М., «МЕДпресс-информ». 2002, с. 245-254.
- Федосеев Г.Б., Трофимов В.И. Бронхиальная астма. СПб., «Нордмедиздат». 2006, 308 с.
- Ильина Н.И., Латышева Е.А. Альвеско: новая молекула и новое средство доставки - новые возможности контроля бронхиальной астмы. Рос. Аллергол. Журн. 2014, № 2, с. 73-78.
- Malmstrom K., Sorva R., Silvasti M. Application and efficacy of the multi-dose dry powder inhaler, Easyhaler, in children with asthma. Pediatr. Allergy Immunol. 1999, v. 10, р. 66-70.
- Palander A., Mattila T., Karka M. et al. In vitro comparison of three salbutamol-containing multidose dry powder inhalers. Clin. Drug Invest. 2000, v. 20, р. 25-33.
- Juntunen-Backman, Kajosaari M., Laurikainen K. et al. Comparison of Easyhaler® metered-dose, dry powder inhaler and a pressurized metered-dose inhaler plus spacer in the treatment of asthma in children. Clin. Drug Invest. 2002, v. 22, p. 827-835.
- Ahonen A., Leinonen M., Ranki-Pesonen M. Patient satisfaction with Easyhaler compared with other inhalation systems in the treatment of asthma: a meta-analysis. Curr. Ther. Res. Clin. Exp. 2000, v. 61, р. 61-73.
- Galffy G., Mezei G., Nemeth G. et al. Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicenter studies in asthma and COPD. Drugs. RD. 2013, v. 13, p. 215-222.
- Панина Н.Т., Илькович М.М. Изихейлеры в практике лечения больных бронхиальной астмой. Тер. Архив. 2013, № 3, с. 98-101.
- Vidgren P., Silvasti M., Poukkula A. et al. Easyhaler powder inhaler - a new alternative in the anti-inflammatory treatment of asthma. Acta Ther. 1994, v. 20, р. 117-131.
- Malmberg L.P., Rytila P., Happonen P., Haahtela T Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters. International Journal of Chronic Obsructive Pulmonary Disease. 2010, v. 5, р. 257-262.
Supplementary files
